¿¡ÇÇÁ¦³×ƽ½º ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°, ¹æ¹ýº°, ±â¹ýº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº° - ¿¹Ãø(-2030³â)
Epigenetics Market by Product & Service (Enzymes, Kits & Reagents, Software), Method, Technique, Application, End User - Global Forecast to 2030
»óǰÄÚµå : 1797404
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 491 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,977,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,373,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,487,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,095,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¿¡ÇÇÁ¦³×ƽ½º ½ÃÀå ±Ô¸ð´Â 2025³â 22¾ï 4,000¸¸ ´Þ·¯¿¡¼­ 2030³â±îÁö 42¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£¿¡ CAGR 13.9%ÀÇ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó ¿¬µµ 2024-2033³â
±âÁØ ¿¬µµ 2024³â
¿¹Ãø ±â°£ 2025-2030³â
´ÜÀ§ 10¾ï ´Þ·¯
ºÎ¹® Á¦°ø, ¹æ¹ý, ±â¹ý, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ(Á¦Ç°), ÃÖÁ¾»ç¿ëÀÚ(¼­ºñ½º), Áö¿ª
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

ÈļºÀ¯ÀüÇÐ ±â¼ú ¹ßÀü, ÈļºÀ¯Àüü ÀǾàǰ ¹× Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½ÃÄö½Ì ºñ¿ë ¹× ½Ã°£ °¨¼Ò µîÀÇ ¿äÀÎÀÌ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª µ¶¼ºÇп¡¼­ ÈļºÀ¯Àüü µ¥ÀÌÅÍÀÇ ¿ëµµ°¡ Á¦ÇÑÀûÀ̰í, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È ¿ì·Á·Î ÀÎÇØ ½ÃÀå È®´ë°¡ Á¦Çѵǰí ÀÖ½À´Ï´Ù.

Epigenetics Market-IMG1

"PCR, qPCR ½ÃÀåÀÌ ´õ ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. "

¸Þƿȭ ƯÀÌÀû PCR ±â¼úÀÇ È°¿ëµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÈļºÀû º¯ÇüÀ» °ËÃâÇÏ´Â ¹Î°¨µµ¿Í ƯÀ̼ºÀÌ Çâ»óµÇ¾î ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

"DNA ¸Þƿȭ°¡ ¹æ¹ý·Ð ºÎ¹®À» µ¶½ÄÇß½À´Ï´Ù. "

2024³â, DNA ¸Þƿȭ°¡ ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¾Ï ¿¬±¸ ºÐ¾ß¿¡¼­ ÀÔÁõµÈ È¿´ÉÀÌ ±× ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, ºñ¾Ïȣȭ RNA ºÐ¼®°ú Å©·Î¸¶Æ¾ ¸®¸ðµ¨¸µÀ» Æ÷ÇÔÇÑ ´ë¾ÈÀû ¹æ¹ýÀÌ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â Çõ½ÅÀûÀÎ ÈļºÀ¯ÀüÇÐÀû ¸ÞÄ¿´ÏÁò°ú Áø´Ü ¹× Ä¡·á °³¹ß¿¡¼­ÀÇ ¹Ì·¡ ¿ªÇÒ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁ³±â ¶§¹®ÀÔ´Ï´Ù.

"¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. "

2024³â ºÏ¹Ì°¡ ÈļºÀ¯ÀüÇÐ ½ÃÀå Á¡À¯À²ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÅÈï °æÁ¦±Ç Àü¹ÝÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ Áö¼ÓÀûÀ¸·Î °³¼±µÊ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °­·ÂÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀåÀº Áö¿ª ³» ¾÷°è ÁøÃâ ±â¾÷µéÀÌ ½ÃÀÛÇÑ Àü·«Àû Á¦ÈÞ, ÆÄÆ®³Ê½Ê, È®Àå ¹× ÇÕÀÇ¿¡ ÀÇÇØ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ¿¡ÇÇÁ¦³×ƽ½º(Epigenetics) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ÁÖ¿ä ÃËÁø¿äÀΰú ÀúÇØ¿äÀÎ, °æÀï ±¸µµ, ÇâÈÄ µ¿Çâ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå Áß¿ä Áö°ß

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ¿¡ÇÇÁ¦³×ƽ½º ½ÃÀå : Á¦°øº°

Á¦7Àå ¿¡ÇÇÁ¦³×ƽ½º ½ÃÀå : ±â¹ýº°

Á¦8Àå ¿¡ÇÇÁ¦³×ƽ½º ½ÃÀå : ¹æ¹ýº°

Á¦9Àå ¿¡ÇÇÁ¦³×ƽ½º ½ÃÀå : ¿ëµµº°

Á¦10Àå ¿¡ÇÇÁ¦³×ƽ½º Á¦Ç° ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ¿¡ÇÇÁ¦³×ƽ½º ¼­ºñ½º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦12Àå ¿¡ÇÇÁ¦³×ƽ½º ½ÃÀå : Áö¿ªº°

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå ±â¾÷ °³¿ä

Á¦15Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global epigenetics market size is projected to reach USD 4.29 billion by 2030 from USD 2.24 billion in 2025, at a CAGR of 13.9% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2033
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsOffering, Method, Technology, Application, End User (Product), End User (Service), and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Factors such as declining sequencing costs and time, along with technological advancements in epigenetics, and a growing demand for epigenetic drugs and diagnostics drive market growth; however, limited applications of epigenomic data in toxicology, along with data privacy and security concerns, restrain market expansion.

Epigenetics Market - IMG1

"The PCR & qPCR market is likely to grow at a faster pace."

The global epigenetics market is categorized by technology into next-generation sequencing (NGS), polymerase chain reaction (PCR) & quantitative PCR (qPCR), mass spectrometry, sonication, and other methodologies. Notably, the PCR & qPCR segment is projected to exhibit significant compound annual growth rate (CAGR). The rising utilization of methylation-specific PCR techniques enhances the sensitivity and specificity of detecting epigenetic modifications, which is anticipated to drive growth in this segment.

"DNA methylation dominated the method segment."

The epigenetics market is categorized by methodology into several segments, primarily DNA methylation, histone modifications, and other techniques. In 2024, DNA methylation dominated the market, primarily due to its established efficacy in cancer research applications. Furthermore, alternative methodologies-including non-coding RNA analysis and chromatin remodeling-are anticipated to exhibit the highest CAGR throughout the forecast period. This is driven by an increasing focus on innovative epigenetic mechanisms and their prospective roles in diagnostics and therapeutic development.

"Asia Pacific region is estimated to show fastest growth rate."

On the basis of region, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America accounted for the major share of the epigenetics market. The Asia Pacific region is projected to experience strong growth during the forecast period, fueled by ongoing improvements in healthcare infrastructure across emerging economies. This market is further boosted by strategic collaborations, partnerships, expansions, and agreements initiated by regional industry players.

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Research Coverage:

This research report categorizes epigenetics market by offering (kits & reagents, enzymes, instruments & accessories, software, and services), method (DNA methylation, Histone modification, and other methods), technology (NGS, PCR & qPCR, mass spectrometry, sonication, and other technologies), application (oncology, metabolic diseases, immunology, developmental biology, cardiovascular diseases, and other applications), end user for product (academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and contract research organizations), end user for service (academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinics) and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The report's scope includes detailed information about the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the epigenetics market. A comprehensive analysis of key industry players has been performed to provide insights into their business overview, solutions, and services; key strategies; new product and service launches, acquisitions, and recent developments related to the epigenetics market. This report also covers the competitive analysis of upcoming startups in the epigenetics industry ecosystem.

Key Benefits of Buying the Report:

The report will assist market leaders and new entrants by providing estimates of revenue for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 EPIGENETICS MARKET, BY OFFERING

7 EPIGENETICS MARKET, BY TECHNOLOGY

8 EPIGENETICS MARKET, BY METHOD

9 EPIGENETICS MARKET, BY APPLICATION

10 EPIGENETICS PRODUCTS MARKET, BY END USER

11 EPIGENETICS SERVICE MARKET, BY END USER

12 EPIGENETICS MARKET, BY REGION

13 COMPETITIVE LANDSCAPE

14 COMPANY PROFILES

15 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â